Antigen-specific immunotherapy of autoimmune and allergic diseases - Wikidata - awgldk - TriplyDB

Antigen-specific immunotherapy of autoimmune and allergic diseases

Antigen-specific immunotherapy of autoimmune and allergic diseases

http://www.wikidata.org/entity/Q37790023

about

Regulation of adaptive immunity; the role of interleukin-10 Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells Future perspectives in target-specific immunotherapies of myasthenia gravis Unmet needs of patients with narcolepsy: perspectives on emerging treatment options Antigen-based immunotherapy for autoimmune disease: current status Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease Organ-specific and memory treg cells: specificity, development, function, and maintenance Vaccine against autoimmune disease: antigen-specific immunotherapy Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.Tolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation.GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis Immune modulating peptides for the treatment and suppression of multiple sclerosis.Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis Protein kinase C theta is required for efficient induction of IL-10-secreting T cells.Can we vaccinate against Type 1 diabetes?Production of the effector cytokine interleukin-17, rather than interferon-γ, is more strongly associated with autoimmune hemolytic anemia.Strategies to circumvent humoral immunity to adeno-associated viral vectors.Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic Design of peptide immunotherapies for MHC Class-II-associated autoimmune disorders.Tolerogenic vaccines for Multiple sclerosis Effector and central memory T helper 2 cells respond differently to peptide immunotherapy.Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice.Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future.Disease modification in multiple sclerosis: an update.Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes.Role of microbial communities in the pathogenesis of periodontal diseases and caries.Optimization of current and future therapy for autoimmune diseases.Response to self antigen imprints regulatory memory in tissues.Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis.Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

P2860

Q21131215-AC10BA37-F5D3-4AC2-B554-86F4EDE34B74 Q26766184-BEB0C97D-4133-4071-8889-E41B7CCFC250 Q26776225-C816C162-D0AF-48EA-9AD4-3C6538A3DB1E Q26827736-C40C5AB9-204D-4F5F-AB74-6F9E648A39DE Q26852915-AFEAF583-519E-42F8-B950-ABA964FAE57A Q27008837-7DC21DBE-4F16-4832-A6FC-1C0EDFA8438A Q27010198-AF9D7D93-5A46-46D4-A5E9-65A064D9EC86 Q27028121-87037543-5B26-4596-B839-5692E6EC739E Q33411662-4EDEE25D-0344-4863-BD5F-B343E7A9A225 Q33694715-391C9A1F-6C5A-4A76-ACF7-1A1D7F7CEB4C Q34065039-88707394-9719-4F23-99BF-0BCFB0257A8D Q34205503-6CE135B2-1464-443F-B7C4-5B1B7FD67A37 Q35060161-B39EB89A-5CE4-44B5-8DBB-92A3240C68B5 Q35318199-B894964C-DA17-4C53-841E-D5DC1DC6C6DC Q35318380-D9A6473B-A4E7-45A4-ADC0-2A07CB43368D Q35571156-3C7057B0-24C7-4A91-9E09-AE1019316188 Q36151968-21B72C68-CBEF-4996-8361-F46E4CA03C81 Q36174813-A65E5EFE-DB90-4A84-A990-7DDABBE7B4AE Q36269823-6BF1DFE2-AF50-49AC-ADFC-1A0A56889AE2 Q36296386-C2EF8422-EBA4-4D45-A541-69B96BC9D409 Q36367048-F00FB8BE-6274-4366-8367-122E42CDA165 Q36398678-7D5D4814-52C8-4FFB-B79A-F2DB7A3E283D Q36536816-791516D0-2373-42EA-89D1-179FA79AA7EF Q37005082-923126E6-B337-4AE0-9331-72FC4D69D55F Q37353611-5B59B1BF-8D6C-402A-A61E-6D2FFE0236F6 Q37505364-83EB40DC-FE15-4FFF-B987-6916B47581D3 Q37612747-42BC2092-F970-422F-8069-368CEC97C9E3 Q37618940-51E37AD4-EF78-4A71-AFD5-DF83B24FB110 Q37694296-0ABC614F-FF35-4FDC-8CE1-7DAA7125E649 Q38068530-D0585783-FCE9-40AF-9EE4-D0F8C2343861 Q38150823-56586F9F-788B-4DED-9027-8207439C435E Q38365254-553E8A46-1F39-463E-B7AA-D2CD2B5EA927 Q38754057-73D8EDC4-4631-4E04-9267-641F889F5F04 Q39165161-2193DFB6-D873-4568-8935-3BD4B2D59A69 Q39666645-0E72C97F-239D-4BF8-9114-30955BA12DA3 Q40573313-BAB5BDB5-E219-437C-A857-1FADB594CF7B Q42678843-796CE985-F0EB-4E9B-A127-DE7259E972D7 Q44129666-8B1BAE8E-A3F3-4174-BA97-357336F4B752 Q45806642-41DC5538-9325-4D75-987E-47BAD4E23EA4 Q45874675-58E091E8-11D9-45A9-A84C-1D93A2BCA36D

P2860

Antigen-specific immunotherapy of autoimmune and allergic diseases

http://www.wikidata.org/entity/Q37790023

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antigen-specific immunotherapy of autoimmune and allergic diseases

@en

Antigen-specific immunotherapy of autoimmune and allergic diseases.

@nl

type

label

Antigen-specific immunotherapy of autoimmune and allergic diseases

@en

Antigen-specific immunotherapy of autoimmune and allergic diseases.

@nl

prefLabel

Antigen-specific immunotherapy of autoimmune and allergic diseases

@en

Antigen-specific immunotherapy of autoimmune and allergic diseases.

@nl

P1433

Q37790023-4C5CD4E8-99A5-4722-8171-95A27A428B26

P1476

Q37790023-F1781C31-EAE3-410C-BDA0-26DD98F1AA8E

P2093

Q37790023-5A64DEE0-B1FC-4B0A-B142-58ECEA067B3A

Q37790023-D789010D-03E0-49FC-8787-49249B396D12

P275

Q37790023-698A9FFF-E683-4667-8A62-06C861C8909E

P2860

Q37790023-054F284B-7CB9-457F-9CC6-A13FA126C6F3

Q37790023-06BD3088-CC1C-4853-B71F-F25BC4191709

Q37790023-218832CD-79CF-45B6-9C14-A81D4CF829F1

Q37790023-38DFD028-0381-4962-BEDE-1127DD8D1D64

Q37790023-43F55151-FA6B-40EC-80C0-F57678CEF96E

Q37790023-56E7F7E7-6802-4FE6-A08F-08F92BD13284

Q37790023-5BCEB3EE-E876-4694-8DF5-8FDD3C0C0CAD

Q37790023-6313BFEE-BFA4-430B-9D6D-8BFADC7B2F66

Q37790023-639F65F8-6C4B-4C53-8441-29A0070FC54C

Q37790023-653AFCED-2F46-45CD-B7DD-1BD0A38F1195

P304

Q37790023-529C3183-31F9-43B8-81F0-C3F10638DB56

P31

Q37790023-BF7DAED0-97B0-4E04-9DEC-D4D1CFF02EC7

P356

Q37790023-8E6382F4-0B79-4326-8A2E-3F4879CAF8F9

P433

Q37790023-C67E78E4-0467-4571-BCF4-0CD9146D8A1D

P478

Q37790023-B1F66519-6041-4208-B6CF-F5A598167F74

P50

Q37790023-CE659E52-E6EB-4DF9-A539-9885081410C5

P577

Q37790023-FB4015D2-A7E1-4E2F-991A-5DF59EF694E1

P5875

Q37790023-9027DA1D-4E05-481D-9F41-9331BBDD4B2E

P698

Q37790023-217D2FCA-3B5A-4686-A796-68A906C60FF5

P921

Q37790023-020A2D28-701F-4AB0-83D7-FDFD53540A22

Q37790023-4465D388-1DDF-4203-B88D-AAAFC18422AE

P932

Q37790023-D3A237DE-6F71-4B9C-865A-5FF433200C9F

P356

J.COI.2010.08.006

P1433

Current Opinion in Immunology

P1476

Antigen-specific immunotherapy of autoimmune and allergic diseases

@en

P2093

Catherine A Sabatos-Peyton

http://www.w3.org/2001/XMLSchema#string

David C Wraith

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatm

The regulation of IL-10 production by immune cells

Oral tolerance: mechanisms and therapeutic applications.

Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.

IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.

Epitope spreading in immune-mediated diseases: implications for immunotherapy.

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.

P304

609-615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COI.2010.08.006

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46305185

http://www.w3.org/2001/XMLSchema#string

P698

20850958

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

2977065

http://www.w3.org/2001/XMLSchema#string